Bjørn Ebdrup
Clinical Professor
1 - 2 out of 2Page size: 10
- 2014
- Published
Glucometabolic hormones and cardiovascular risk markers in antipsychotic-treated patients
Ebdrup, Bjørn, Knop, Filip Krag, Madsen, A., Mortensen, H. B., Søgaard, B., Holst, Jens Juul, Szecsi, P. B. & Lublin, H., Sep 2014, In: Journal of Clinical Psychiatry. 75, 9, p. e899-905 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist-protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: The TAO study protocol
Ishøy, P. L., Knop, Filip Krag, Broberg, B. V., Baandrup, Lone, Fagerlund, Birgitte, Jørgensen, Niklas Rye, Andersen, U. B., Rostrup, Egill, Glenthøj, Birte Yding & Ebdrup, Bjørn, 2014, In: BMJ Open. 4, 1, e004158.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 6453545
Most downloads
-
291
downloads
TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
200
downloads
Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
178
downloads
Effect of GLP-1 Receptor Agonist Treatment on Body weight in Obese Antipsychotic-treated Patients with Schizophrenia: a Randomized, Placebo-controlled Trial Byline
Research output: Contribution to journal › Journal article › Research › peer-review
Published